Astellas and seagen announce chmp confirms positive opinion for padcev™ (enfortumab vedotin) in locally advanced or metastatic urothelial cancer

Tokyo and bothell, wash., feb. 28, 2022 /prnewswire/ -- astellas pharma inc. (tse:4503, president and ceo: kenji yasukawa, ph.d.

SGEN Ratings Summary

SGEN Quant Ranking